Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors.

Chícharo, Ana Teodósio; Lopes, Ana R; Barreira, Sofia; Pinto, Luísa; Cruz-Machado, Ana R; Capela, Susana.

Affiliation

Chícharo AT; Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center, European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ERN-ReCONNET) and RITA Full Member, Lisbon, Portugal.
Lopes AR; Rheumatology Department, Centro Hospitalar Universitário do Algarve, Hospital de Faro, Faro, Portugal.
Barreira S; Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center, European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ERN-ReCONNET) and RITA Full Member, Lisbon, Portugal.
Pinto L; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Cruz-Machado AR; Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center, European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ERN-ReCONNET) and RITA Full Member, Lisbon, Portugal.
Capela S; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.

Rheumatol Adv Pract ; 8(2): rkae044, 2024.

Article in En | MEDLINE | ID: mdl-38590951

Full text: 1 Database: MEDLINE Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Language: En Year: 2024 Type: Article